Skip to content

Chemed CHE Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$66.3M-7.6%$76.75M-15.0%$64.24M-15.2%$52.49M-25.9%$71.76M+10.4%
$16.87M+5.3%$16.33M+3.2%$16.23M+3.4%$16.26M+3.5%$16.02M+1.3%
$9.25M+1.7%$14.31M-49.2%$6.07M+0.5%$9.22M+3.9%$9.09M+0.7%
-$4.74M+66.6%-$3.02M-$14.17M-161%
$80K0.0%$80K0.0%$81K0.0%$80K0.0%$80K0.0%
$32.9M-51.2%$30.94M+160%$67.42M+1,361%
-$335K+16.9%-$695K+59.3%-$910K-8.9%$1.36M-$403K+69.0%
$2.24M+110%-$15.3M$22.55M+15,981%-$22.59M+47.5%
$3.6M+219%-$45.39M-1,554%-$3.03M-125%
$6.71M+605%$4.07M-7.5%$4.83M+84.6%$570K-76.2%$951K-92.9%
$31K-80.1%$445K-13.3%$38K-84.6%$156K-61.6%
$88K-98.0%$1.37M-44.0%$2.8M$4.43M+332%
$26.82M-28.1%-$4.06M-160%-$48.05M-38.7%$37.29M+56.2%
$2.58M+1.0%$2.58M+1.0%$2.58M+1.0%$2.58M+1.0%
$17.21M+2.0%$17.28M+5.3%$17.36M+4.9%$17.11M+8.2%$16.88M+8.3%
$9.92M+85.2%$10.88M+8.5%$10.41M+17.3%$5.73M-15.9%$5.36M-60.1%
$88.22M+169%$133.53M-19.0%$83.39M-7.9%$138.61M+78.8%$32.74M-61.3%
$17.12M+28.9%$16.35M+28.1%$17.5M-6.2%$15.81M-83.6%$13.28M+9.2%
$20.61M+9,060%$225K-96.9%
$197K-29.9%$420K+2,900%$146K+813%$41K-84.0%$281K+3,413%
$134K+19.6%$817K+220%$3.27M+2,172%$368K-87.0%$112K+30.2%
-$37.79M-176%-$15.95M-27.4%-$14.23M+23.1%-$15.48M+83.4%-$13.67M+29.5%
$8.17M+11.6%$8.5M+13.4%$8.65M+15.6%$7.22M+19.2%$7.33M+21.1%
$190.04M+472%$174.56M-16.6%$180.78M+213%$42.95M-23.0%$33.22M-13.6%
$44.28M
$1.31M-94.2%$4.49M+232%$22.67M-39.1%
$1.48M-76.3%$335K-46.8%$0-100%$2.23M+849%$6.25M+9.2%
-$414K-360%$211K+113%$933K+802%$159K+124%
-$108.09M-359%-$172.82M+18.7%-$189.31M-235%-$47.1M+36.8%-$23.54M-49.2%
-5,765,900,000%-5,319,100,000%-10,383,500,000%-1,822,700,000%-446,800,000%-5,386,000,000%
$336.25K+15.8%$336.25K+15.8%$336.25K+15.8%$336.25K+15.8%
$25.68M+4.0%$25.68M+4.0%$25.68M+4.0%$25.68M+4.0%
$9.67M-25.8%$9.67M-25.8%$9.67M-25.8%$9.67M-25.8%
$80K0.0%$80K0.0%$81K0.0%$80K0.0%$80K0.0%
$2.58M+1.0%$2.58M+1.0%$2.58M+1.0%$2.58M+1.0%
$1.08M0.0%$1.08M0.0%$1.08M0.0%$1.08M0.0%
$471K+379%$230K-16.1%$504K+73.2%$241K+79.9%-$169K-576%
$3.6M+219%-$45.39M-1,554%-$3.03M-125%
$88K-98.0%$1.37M-44.0%$2.8M$4.43M+332%
$890K-57.1%$1.56M-51.4%$2.56M-30.3%$2.56M-26.9%$2.08M-51.1%
$20.25K+101%$20.25K+101%$20.25K+101%$20.25K+101%
$1.39M-42.7%$1.83M-39.3%$0-100%$853K-76.3%$2.42M-73.4%
$9.25M+1.7%$8.3M+2.4%$6.07M+0.5%$9.22M+3.9%$9.09M+0.7%
$197K-29.9%$420K+2,900%$146K+813%$41K-84.0%$281K+3,413%
$134K+19.6%$817K+220%$3.27M+2,172%$368K-87.0%$112K+30.2%
-$493K-213%$10.36M$301K$0+100%$438K+121%
-$414K-360%$211K+113%$933K+802%$159K+124%
$44.28M
$441.75M+2.6%$414.17M+2.0%$427.99M+8.0%$434.11M+11.4%$430.53M+11.8%
$441.75M+2.6%$414.17M+2.0%$427.99M+8.0%$434.11M+11.4%$430.53M+11.8%
$572.94M+3.8%$538.68M+2.4%$550.15M+7.0%$550.71M+8.5%$552.19M+6.8%
-$1.49M-43.5%-$1.49M-43.5%-$1.49M-43.5%-$1.49M-43.5%
25.4%+0.4%25.4%+1.0%23.1%-1.9%26.2%+1.7%25%+2.0%
-$1.92M-$1.74M-210%-$1.54M-175%
-$18K-264%$12K+111%$56K+722%$11K+123%
$512K+55.6%$521K+4.4%$457K+7.0%$443K+3.3%$329K-22.6%
$44.8M+3.1%$41.63M-5.9%$44.47M+10.4%$40.52M-2.9%$43.45M+4.6%
$66.3M-7.6%$76.75M-15.0%$64.24M-15.2%$52.49M-25.9%$71.76M+10.4%
$4.77M+283%$5.31M-21.2%$9.25M-0.5%$3.47M-43.3%$1.25M-90.1%
0.50.0%0.50.0%0.50.0%0.50.0%
$36.73M+14.0%$32.77M+10.4%$35.92M+5.1%$30.79M+0.2%$32.23M-12.1%
$135.48M
$657.51M+1.6%$639.34M-0.1%$624.9M+3.1%$618.8M+3.8%$646.94M+9.8%
$14.72M-8.0%$14.92M+144%$8.7M-42.8%$13.07M+9.0%$15.99M-3.4%
85.8-25.1%
$31K-13.9%$29K-69.5%$28K-72.8%$30K-66.7%$36K+56.5%
$71.1M+265%$117.19M-23.0%$66.03M-14.2%$122.8M+84.8%$19.46M-73.1%
$71.1M+265%$117.19M-23.0%$66.03M-14.2%$122.8M+84.8%$19.46M-73.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Chemed generate?
Chemed (CHE) generated $443.7M in operating cash flow over the trailing twelve months.
What is Chemed's free cash flow?
After $66.8M of capital expenditures, Chemed's free cash flow was $377.1M over the trailing twelve months, up 19.7% year over year.
Where does Chemed's cash flow data come from?
Every line is extracted from Chemed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.